BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1161 related articles for article (PubMed ID: 2535852)

  • 1. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
    Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies.
    Klibanski A; Deutsch PJ; Jameson JL; Ridgway EC; Crowley WF; Hsu DW; Habener JF; Black PM
    J Clin Endocrinol Metab; 1987 Mar; 64(3):536-42. PubMed ID: 3102541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas.
    Sassolas G; Lejeune H; Trouillas J; Forest MG; Claustrat B; Lahlou N; Loras B
    J Clin Endocrinol Metab; 1988 Jul; 67(1):180-5. PubMed ID: 2967850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
    Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
    J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of gonadotropin-releasing hormone (GnRH) receptor gene is altered by GnRH agonist desensitization in a manner similar to that of gonadotropin beta-subunit genes in normal and castrated rat pituitary.
    Lerrant Y; Kottler ML; Bergametti F; Moumni M; Blumberg-Tick J; Counis R
    Endocrinology; 1995 Jul; 136(7):2803-8. PubMed ID: 7789305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist.
    Daneshdoost L; Pavlou SN; Molitch ME; Gennarelli TA; Savino PJ; Sergott RC; Bosley TM; River JE; Vale WW; Snyder PJ
    J Clin Endocrinol Metab; 1990 Jul; 71(1):92-7. PubMed ID: 2115048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function correlations of human pituitary gonadotroph adenomas in vitro.
    Asa SL; Gerrie BM; Kovacs K; Horvath E; Singer W; Killinger DW; Smyth HS
    Lab Invest; 1988 Apr; 58(4):403-10. PubMed ID: 2451766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicle-stimulating hormone-secreting pituitary tumor with concomitant elevation of serum alpha-subunit levels.
    Borges JL; Ridgway EC; Kovacs K; Rogol AD; Thorner MO
    J Clin Endocrinol Metab; 1984 May; 58(5):937-41. PubMed ID: 6200493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone differentially modulates gonadotropin subunit messenger ribonucleic acid responses to gonadotropin-releasing hormone pulse amplitude.
    Iliff-Sizemore SA; Ortolano GA; Haisenleder DJ; Dalkin AC; Krueger KA; Marshall JC
    Endocrinology; 1990 Dec; 127(6):2876-83. PubMed ID: 1701131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of testosterone on gonadotropin subunit messenger ribonucleic acids in the presence or absence of gonadotropin-releasing hormone.
    Winters SJ; Ishizaka K; Kitahara S; Troen P; Attardi B
    Endocrinology; 1992 Feb; 130(2):726-34. PubMed ID: 1370794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic GnRH analogue administration on gonadotrophin and alpha-subunit secretion in post-menopausal women.
    Oppenheim DS; Bikkal H; Crowley WF; Klibanski A
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):559-64. PubMed ID: 1385024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasts in the gonadotropin-releasing hormone dose-response relationships for luteinizing hormone, follicle-stimulating hormone and alpha-subunit release in young versus older men: appraisal with high-specificity immunoradiometric assay and deconvolution analysis.
    Zwart AD; Urban RJ; Odell WD; Veldhuis JD
    Eur J Endocrinol; 1996 Oct; 135(4):399-406. PubMed ID: 8921820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of pituitary gonadotropin secretion by 4-aminopyrazolo(3,4-d) pyrimidine.
    Blank MS; Loumaye E; Sgoutas DS; Catt KJ; Dufau ML
    Endocrinology; 1983 Jun; 112(6):1973-9. PubMed ID: 6406206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists.
    Hall JE; Whitcomb RW; Rivier JE; Vale WW; Crowley WF
    J Clin Endocrinol Metab; 1990 Feb; 70(2):328-35. PubMed ID: 2105329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture.
    Snyder PJ; Bashey HM; Phillips JL; Gennarelli TA
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1061-5. PubMed ID: 2414310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
    Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
    J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of insulin-like growth factor 1 on the hormonal product and proliferation of glycoprotein-secreting human pituitary adenomas.
    Atkin SL; Landolt AM; Jeffreys RV; Hipkin L; Radcliffe J; Squire CR; White MC
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1059-66. PubMed ID: 7691862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.